# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-20-000061
Filing Date
2020-05-08
Accepted
2020-05-08 16:28:04
Documents
63
Period of Report
2020-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20200331.htm iXBRL | 10-Q | 1614318
2 | EX-2.1 | exhibit21assetpurchase.htm | EX-2.1 | 866866
3 | EX-10.1 | ligand-exhibit101tofor.htm | EX-10.1 | 38876
4 | EX-10.2 | ligand-exhibit102tofor.htm | EX-10.2 | 48953
5 | EX-10.3 | ligand-exhibit103tofor.htm | EX-10.3 | 51732
6 | EX-31.1 | lgnd33120exhibit311.htm | EX-31.1 | 21054
7 | EX-31.2 | lgnd33120exhibit312.htm | EX-31.2 | 21396
8 | EX-32.1 | lgnd33120exhibit321.htm | EX-32.1 | 15366
14 |  | image01.jpg | GRAPHIC | 5721
15 |  | lgnd-20200331_g1.jpg | GRAPHIC | 11735
| Complete submission text file | 0000886163-20-000061.txt |  | 8613361

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20200331.xsd | EX-101.SCH | 41180
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20200331_cal.xml | EX-101.CAL | 101216
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20200331_def.xml | EX-101.DEF | 232392
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20200331_lab.xml | EX-101.LAB | 601466
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20200331_pre.xml | EX-101.PRE | 369140
52 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20200331_htm.xml | XML | 1456495

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 20860990
SIC: 2834 Pharmaceutical Preparations